SELLAS Life Sciences Group, Inc. (SLS) › Net IncomeSELLAS Life Sciences Group, Inc. (SLS) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$11.99M2011: -$11.48M2012: -$34.97M2013: -$76.68M2014: -$36.61M2015: -$63.90M2016: -$17.68M2017: -$23.75M2018: -$27.67M2019: -$19.29M2020: -$16.76M2021: -$20.70M2022: -$41.30M2023: -$37.34M2024: -$30.88M2025: -$26.86M-$26.86M2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$26.86M+13.0%2024-$30.88M+17.3%2023-$37.34M+9.6%2022-$41.30M-99.5%2021-$20.70M-23.5%2020-$16.76M+13.1%2019-$19.29M+30.3%2018-$27.67M-16.5%2017-$23.75M-34.3%2016-$17.68M+72.3%2015-$63.90M-74.6%2014-$36.61M+52.3%2013-$76.68M-119.3%2012-$34.97M-204.5%2011-$11.48M+4.2%2010-$11.99M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share